130 (Mycophenolate Mofetil 250 mg)
Pill with imprint 130 is Blue & White, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Zydus Pharmaceuticals.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 130
- 250 mg
- Blue & White
- 19.00 mm
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals
- National Drug Code (NDC)
- Inactive Ingredients
croscarmellose sodium, FD&C Blue No. 1, FD&C Red No. 3, magnesium stearate, gelatin, sodium lauryl sulfate, titanium dioxide, povidone k90, pregelatinized corn starch, silicon dioxide
Note: Inactive ingredients may vary.
Related Images for "130"
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 50 Reviews
- Drug class: selective immunosuppressants
- FDA Alerts (3)
- Mycophenolate mofetil oral/injection
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- ... +2 more
Other brands: CellCept
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.